Evidence map›Paper›PMID 34719984›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.

Concetta Lipardi, C Gregory Elliott, Chiara L Sugarmann, Lloyd Haskell, Alex C Spyropoulos, Gary E Raskob, Jianfeng Xu, Wentao Lu, Jessica Marsigliano, Theodore Spiro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Concetta Lipardi6808Janssen Research and Development, LLC, Raritan, NJ, USA.ORCID https://orcid.org/0000-0002-3815-2259
C Gregory ElliottIntermountain Medical Center, Murray, UT, USA.
Chiara L Sugarmann6808Janssen Research and Development, LLC, Raritan, NJ, USA.ORCID https://orcid.org/0000-0003-2040-6983
Lloyd Haskell6808Janssen Research and Development, LLC, Raritan, NJ, USA.
Alex C Spyropoulos232890The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.ORCID https://orcid.org/0000-0002-3175-461X
Gary E RaskobHudson College of Public Health, 51166University of Oklahoma Health Sciences Center, OK, USA.
Jianfeng Xu6808Janssen Research and Development, LLC, Raritan, NJ, USA.
Wentao Lu6808Janssen Research and Development, LLC, Raritan, NJ, USA.
Jessica Marsigliano6808Janssen Research and Development, LLC, Raritan, NJ, USA.ORCID https://orcid.org/0000-0003-3750-4424
Theodore SpiroBayer US, LLC, Whippany, NJ, USA.
Zhong Yuan6808Janssen Research and Development, LLC, Titusville, NJ, USA.
Shujian Wu6808Janssen Research and Development, LLC, Horsham, PA, USA.
Elliot S Barnathan6808Janssen Research and Development, LLC, Raritan, NJ, USA.
Janssen (United States) · USBayer (United States) · USIntermountain Medical Center · USNorthwell Health · USUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute DiseaseAdultBronchiectasisFactor Xa InhibitorsFemaleHemorrhageHumansIncidenceMaleRisk FactorsRivaroxabanVenous ThromboembolismFactor Xa InhibitorsRivaroxabanbronchiectasismedically ill patientssevere bleedingthromboprophylaxis

Identifiers

PMID34719984
PMCPMC8559236
OpenAlexW3209072127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.